In vivo experiments have demonstrated that anti‐PD‐L1 antibodies promote the death of both CAFs and cancer cells, resulting in an increase in CD8+ T cells and a reduction in FoxP3+ Treg cells [124]. Here, CD274 is linked to cancer.